# Progress Note 07 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Robert Peary (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EX004-SYN
- Date: 2026-04-28
- Fictional facility: St. Posthumous Health Center
- Fictional author: Thaddeus Lindgren-Okafor, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Fifteen-week review: neurological recovery, iron and lifelong maintenance. **S**

## History of present illness

Admiral Peary returns fifteen weeks after starting treatment. He walks two miles a day with his stick, mostly for safety on rough ground, and has had no falls. The numbness at the ends of his feet is less but has changed little over the past month. He has taken the iron every other day without stomach upset and has given himself every weekly injection. His feet have stayed whole, and podiatry has booked his next visit. He is writing again for several hours a day. His HIV, hepatitis C and hepatitis B tests from the preventive visit were negative, and he was told by phone. He asked whether he could take tablets instead of injections. **S**

| Element | Detail |
|---|---|
| Hemoglobin | 14.8 g/dL; MCV 90 fL |
| Iron | Ferritin 64 ng/mL; saturation 27% |
| Nerves | Romberg negative; vibration reduced at the ankles; numbness at the ends of the feet, little change in a month |
| Mood and cognition | PHQ-9 2; MoCA 28 |
| Screening results | HIV, hepatitis C and hepatitis B negative |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy normal |
| Gastrointestinal | Negative | No indigestion, constipation or black stools on iron |
| Neurological | Positive | Numbness at the ends of the feet; balance much better |
| Psychiatric | Negative | Mood good; PHQ-9 2 |

4 systems reviewed. **S**

## Current medications

- Cyanocobalamin (vitamin B12) 1,000 micrograms (1 mg/mL) intramuscular injection once a month for life **S**
- Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet every other day on an empty stomach with a glass of orange juice **S**

## Allergies

- No known allergy **S**

## Objective

BP 128/76 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 74.6 kg; BMI 22.3 kg/m². All vital signs are synthetic.

Hemoglobin: 14.8 g/dL; MCV: 90 fL; RDW: 13.8%; Ferritin: 64 ng/mL; Transferrin saturation: 27%; PHQ-9: 2; MoCA: 28. All results are synthetic.

## Change since baseline

- Hemoglobin: 8.2 g/dL (low) at baseline, 14.8 g/dL at this visit **S**
- MCV: 118 fL (high) at baseline, 90 fL at this visit **S**
- RDW: 19.6% (high) at baseline, 13.8% at this visit **S**
- Ferritin: 62 ng/mL at baseline, 64 ng/mL at this visit **S**
- Transferrin saturation: 55% (high) at baseline, 27% at this visit **S**
- PHQ-9: 6 at baseline, 2 at this visit **S**
- MoCA: 27 at baseline, 28 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 128/76, pulse 70 |
| Neurological | Vibration reduced but present at the ankles; joint position sense normal; ankle jerks absent; Romberg negative; Timed Up and Go 10 seconds; MoCA 28 |
| Feet | Skin intact; callus small; monofilament felt at 7 of 10 sites on each forefoot |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Pernicious anemia** (D51.0). Hemoglobin and MCV normal. Because the cause is autoimmune gastritis, replacement is lifelong. High-dose oral cyanocobalamin, at least 1 mg a day, works for many people, because about 1 percent of a large dose is absorbed without intrinsic factor; with past nerve damage, intramuscular maintenance is the more certain choice, and he chose to stay on injections. **S**
   - Cyanocobalamin 1,000 micrograms into the muscle every four weeks for life, self-injected.
   - Blood count in three months, then every year; vitamin B12 levels not rechecked routinely.
2. **Subacute combined degeneration** (G32.0). Balance has recovered and vibration is returning; the numbness at the ends of the feet has changed little over the past month and may be partly permanent. **S**
   - Finish physical therapy with a home program.
   - Neurological examination at each review.
3. **Iron deficiency** (E61.1). Ferritin 64 ng/mL and saturation 27% after seven weeks of oral iron. **S**
   - Continue ferrous sulfate every other day for three more months, then ferritin and blood count.
4. **Falls** (Z91.81). No falls since intake; Timed Up and Go 10 seconds, from 14. **S**
   - Night lights, the stick on rough ground, and care on ice.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Symptoms: fatigue, breathlessness, exercise tolerance, sore tongue, numbness | Every visit during active treatment | Completed today | No fatigue or breathlessness; numbness at the ends of the feet |
| Laboratory | Blood count with MCV | In three months, then yearly | Completed today | Hemoglobin 14.8 g/dL, MCV 90 fL, RDW 13.8% |
| Laboratory | Iron studies (ferritin, transferrin saturation) | When the blood count recovers, and about three months into oral iron | Completed today | Ferritin 64 ng/mL and saturation 27% on oral iron |
| Laboratory | Serum vitamin B12 | Not routinely after replacement starts | Not indicated | Not rechecked |
| Medication safety | Injection plan: doses given, self-injection technique, site problems | Every visit | Completed today | Every weekly injection given; monthly maintenance from today |
| Examination | Neurological examination: vibration, joint position, reflexes, Romberg, gait, cognition | At diagnosis and at follow-up visits for six weeks to three months, then until recovery levels off | Completed today | Romberg negative; vibration reduced at the ankles; ankle jerks absent; recovery levelling off |
| Examination | Falls and gait: falls since the last visit, Timed Up and Go, home hazards | Every visit | Completed today | No falls; Timed Up and Go 10 seconds |
| Survey | Mood (PHQ-9) and cognition (MoCA) | At intake and after treatment | Completed today | PHQ-9 2, item 9 scored 0, from 6; MoCA 28, from 27 |
| Examination | Upper endoscopy with Sydney-protocol biopsies for autoimmune gastritis, neuroendocrine tumors and dysplasia | At diagnosis of pernicious anemia; then by individual risk | Up to date | Next endoscopy in three years |
| Self-management | Feet: daily skin checks, footwear, callus and stump skin, monofilament | Every visit | Completed today | Skin intact; daily checks kept; monofilament felt at 7 of 10 sites |
| Referral | Podiatry | Within four weeks of intake, then every three months | Up to date | Next visit booked for next month |

## Goal progress

- Find the cause of the anemia and the numb feet. Outcome by 2026-01-21: Pernicious anemia confirmed: intrinsic factor and parietal cell antibodies positive, gastrin high. **S**
- Normal hemoglobin and MCV within eight weeks. Outcome by 2026-03-10: Hemoglobin 8.2 to 14.1 g/dL and MCV 118 to 91 fL at eight weeks. **S**
- Recover feeling and balance in the feet and walk without falls. In progress; target 2026-10-27. **S**
- No foot wound that goes unnoticed. In progress; target 2026-10-27. **S**
- Gastric surveillance planned with him. Outcome by 2026-03-10: Endoscopy without neuroendocrine tumor or dysplasia; repeat in three years by shared decision. **S**

## Medication changes

- Started: Cyanocobalamin (vitamin B12) 1,000 micrograms (1 mg/mL) intramuscular injection once a month for life **S**

## Guideline basis

- Guidelines for the diagnosis and treatment of cobalamin and folate disorders (2014), British Committee for Standards in Haematology (British Journal of Haematology 2014;166(4):496-513)
- Vitamin B12 deficiency in over 16s: diagnosis and management (NG239) (2024), National Institute for Health and Care Excellence
- AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review (2021), American Gastroenterological Association (Gastroenterology 2021;161(4):1325-1332)
- CMID: Clinical Monitoring Intelligence Database, anemia and depression, bipolar, and mood disorders monographs (2026), Aether Forge
- Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update) (2023), International Working Group on the Diabetic Foot (Diabetes/Metabolism Research and Reviews 2024;40(3):e3651)
- Falls Prevention in Community-Dwelling Older Adults: Interventions (2024), U.S. Preventive Services Task Force
- Depression and Suicide Risk in Adults: Screening (2023), U.S. Preventive Services Task Force

## Follow-up

- Monthly self-injection. Blood count, ferritin and saturation in three months. TSH and blood count yearly. Endoscopy in three years. Podiatry every three months. Second zoster dose by the autumn. **S**

